FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy
Open Access
- 2 September 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13596
Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) are deadly sarcomas, which desperately need effective therapies. Half of all MPNSTs arise in patients with neurofibromatosis type I (NF1), a common inherited disease. NF1 patients can develop benign lesions called plexiform neurofibromas (PNFs), often in adolescence, and over time, some PNFs, but not all, will transform into MPNSTs. A deeper understanding of the molecular and genetic alterations driving PNF–MPNST transformation will guide development of more targeted and effective treatments for these patients. This review focuses on an oncogenic transcription factor, FOXM1, which is a powerful oncogene in other cancers but little studied in MPNSTs. Elevated expression of FOXM1 was seen in patient MPNSTs and correlated with poor survival, but otherwise, its role in the disease is unknown. We discuss what is known about FOXM1 in MPNSTs relative to other cancers and how FOXM1 may be regulated by and/or regulate the most commonly altered players in MPNSTs, particularly in the MEK and CDK4/6 kinase pathways. We conclude by considering FOXM1, MEK, and CDK4/6 as new, clinically relevant targets for MPNST therapy.Keywords
All Related Versions
Funding Information
- National Institutes of Health (R01 NS119322, P30 CA086862)
This publication has 147 references indexed in Scilit:
- Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasmsActa Neuropathologica, 2011
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer CellsCancer Cell, 2011
- Deregulation of FoxM1b leads to tumour metastasisEMBO Molecular Medicine, 2010
- Increased expression of FoxM1 transcription factor in respiratory epithelium inhibits lung sacculation and causes Clara cell hyperplasiaDevelopmental Biology, 2010
- PTEN dosage is essential for neurofibroma development and malignant transformationProceedings of the National Academy of Sciences, 2009
- The first 30 years of p53: growing ever more complexNature Reviews Cancer, 2009
- Pro-proliferative FoxM1 is a target of p53-mediated repressionOncogene, 2009
- Identification and Characterization of RBEL1 Subfamily of GTPases in the Ras Superfamily Involved in Cell Growth RegulationJournal of Biological Chemistry, 2009
- Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progressionNature Cell Biology, 2008
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993